Metabolic Disorder Therapeutics Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metabolic Disorder Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Lysosomal Storage Diseases
1.2.3 Diabetes
1.2.4 Obesity
1.2.5 Inherited Metabolic Disorders
1.2.6 Hypercholesterolemia
1.3 Market by Application
1.3.1 Global Metabolic Disorder Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oral
1.3.3 Parenteral
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Metabolic Disorder Therapeutics Market Perspective (2017-2028)
2.2 Metabolic Disorder Therapeutics Growth Trends by Region
2.2.1 Metabolic Disorder Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Metabolic Disorder Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Metabolic Disorder Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Metabolic Disorder Therapeutics Market Dynamics
2.3.1 Metabolic Disorder Therapeutics Industry Trends
2.3.2 Metabolic Disorder Therapeutics Market Drivers
2.3.3 Metabolic Disorder Therapeutics Market Challenges
2.3.4 Metabolic Disorder Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Metabolic Disorder Therapeutics Players by Revenue
3.1.1 Global Top Metabolic Disorder Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Metabolic Disorder Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Metabolic Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Metabolic Disorder Therapeutics Revenue
3.4 Global Metabolic Disorder Therapeutics Market Concentration Ratio
3.4.1 Global Metabolic Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metabolic Disorder Therapeutics Revenue in 2021
3.5 Metabolic Disorder Therapeutics Key Players Head office and Area Served
3.6 Key Players Metabolic Disorder Therapeutics Product Solution and Service
3.7 Date of Enter into Metabolic Disorder Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Metabolic Disorder Therapeutics Breakdown Data by Type
4.1 Global Metabolic Disorder Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Metabolic Disorder Therapeutics Forecasted Market Size by Type (2023-2028)
5 Metabolic Disorder Therapeutics Breakdown Data by Application
5.1 Global Metabolic Disorder Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Metabolic Disorder Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Metabolic Disorder Therapeutics Market Size (2017-2028)
6.2 North America Metabolic Disorder Therapeutics Market Size by Type
6.2.1 North America Metabolic Disorder Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Metabolic Disorder Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Metabolic Disorder Therapeutics Market Share by Type (2017-2028)
6.3 North America Metabolic Disorder Therapeutics Market Size by Application
6.3.1 North America Metabolic Disorder Therapeutics Market Size by Application (2017-2022)
6.3.2 North America Metabolic Disorder Therapeutics Market Size by Application (2023-2028)
6.3.3 North America Metabolic Disorder Therapeutics Market Share by Application (2017-2028)
6.4 North America Metabolic Disorder Therapeutics Market Size by Country
6.4.1 North America Metabolic Disorder Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Metabolic Disorder Therapeutics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Metabolic Disorder Therapeutics Market Size (2017-2028)
7.2 Europe Metabolic Disorder Therapeutics Market Size by Type
7.2.1 Europe Metabolic Disorder Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Metabolic Disorder Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Metabolic Disorder Therapeutics Market Share by Type (2017-2028)
7.3 Europe Metabolic Disorder Therapeutics Market Size by Application
7.3.1 Europe Metabolic Disorder Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Metabolic Disorder Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Metabolic Disorder Therapeutics Market Share by Application (2017-2028)
7.4 Europe Metabolic Disorder Therapeutics Market Size by Country
7.4.1 Europe Metabolic Disorder Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Metabolic Disorder Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Metabolic Disorder Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Metabolic Disorder Therapeutics Market Size by Type
8.2.1 Asia-Pacific Metabolic Disorder Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Metabolic Disorder Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Metabolic Disorder Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Metabolic Disorder Therapeutics Market Size by Application
8.3.1 Asia-Pacific Metabolic Disorder Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Metabolic Disorder Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Metabolic Disorder Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific Metabolic Disorder Therapeutics Market Size by Region
8.4.1 Asia-Pacific Metabolic Disorder Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Metabolic Disorder Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Metabolic Disorder Therapeutics Market Size (2017-2028)
9.2 Latin America Metabolic Disorder Therapeutics Market Size by Type
9.2.1 Latin America Metabolic Disorder Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Metabolic Disorder Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Metabolic Disorder Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Metabolic Disorder Therapeutics Market Size by Application
9.3.1 Latin America Metabolic Disorder Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America Metabolic Disorder Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America Metabolic Disorder Therapeutics Market Share by Application (2017-2028)
9.4 Latin America Metabolic Disorder Therapeutics Market Size by Country
9.4.1 Latin America Metabolic Disorder Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Metabolic Disorder Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Metabolic Disorder Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Metabolic Disorder Therapeutics Market Size by Type
10.2.1 Middle East & Africa Metabolic Disorder Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Metabolic Disorder Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Metabolic Disorder Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Metabolic Disorder Therapeutics Market Size by Application
10.3.1 Middle East & Africa Metabolic Disorder Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Metabolic Disorder Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Metabolic Disorder Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa Metabolic Disorder Therapeutics Market Size by Country
10.4.1 Middle East & Africa Metabolic Disorder Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Metabolic Disorder Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novo Nordisk A/S
11.1.1 Novo Nordisk A/S Company Details
11.1.2 Novo Nordisk A/S Business Overview
11.1.3 Novo Nordisk A/S Metabolic Disorder Therapeutics Introduction
11.1.4 Novo Nordisk A/S Revenue in Metabolic Disorder Therapeutics Business (2017-2022)
11.1.5 Novo Nordisk A/S Recent Developments
11.2 Sanofi S.A.
11.2.1 Sanofi S.A. Company Details
11.2.2 Sanofi S.A. Business Overview
11.2.3 Sanofi S.A. Metabolic Disorder Therapeutics Introduction
11.2.4 Sanofi S.A. Revenue in Metabolic Disorder Therapeutics Business (2017-2022)
11.2.5 Sanofi S.A. Recent Developments
11.3 Boehringer Ingelheim GmbH
11.3.1 Boehringer Ingelheim GmbH Company Details
11.3.2 Boehringer Ingelheim GmbH Business Overview
11.3.3 Boehringer Ingelheim GmbH Metabolic Disorder Therapeutics Introduction
11.3.4 Boehringer Ingelheim GmbH Revenue in Metabolic Disorder Therapeutics Business (2017-2022)
11.3.5 Boehringer Ingelheim GmbH Recent Developments
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Company Details
11.4.2 Eli Lilly and Company Business Overview
11.4.3 Eli Lilly and Company Metabolic Disorder Therapeutics Introduction
11.4.4 Eli Lilly and Company Revenue in Metabolic Disorder Therapeutics Business (2017-2022)
11.4.5 Eli Lilly and Company Recent Developments
11.5 Merck KgaA
11.5.1 Merck KgaA Company Details
11.5.2 Merck KgaA Business Overview
11.5.3 Merck KgaA Metabolic Disorder Therapeutics Introduction
11.5.4 Merck KgaA Revenue in Metabolic Disorder Therapeutics Business (2017-2022)
11.5.5 Merck KgaA Recent Developments
11.6 Amgen, Inc.
11.6.1 Amgen, Inc. Company Details
11.6.2 Amgen, Inc. Business Overview
11.6.3 Amgen, Inc. Metabolic Disorder Therapeutics Introduction
11.6.4 Amgen, Inc. Revenue in Metabolic Disorder Therapeutics Business (2017-2022)
11.6.5 Amgen, Inc. Recent Developments
11.7 AstraZeneca PLC
11.7.1 AstraZeneca PLC Company Details
11.7.2 AstraZeneca PLC Business Overview
11.7.3 AstraZeneca PLC Metabolic Disorder Therapeutics Introduction
11.7.4 AstraZeneca PLC Revenue in Metabolic Disorder Therapeutics Business (2017-2022)
11.7.5 AstraZeneca PLC Recent Developments
11.8 Actelion Pharmaceuticals Ltd.
11.8.1 Actelion Pharmaceuticals Ltd. Company Details
11.8.2 Actelion Pharmaceuticals Ltd. Business Overview
11.8.3 Actelion Pharmaceuticals Ltd. Metabolic Disorder Therapeutics Introduction
11.8.4 Actelion Pharmaceuticals Ltd. Revenue in Metabolic Disorder Therapeutics Business (2017-2022)
11.8.5 Actelion Pharmaceuticals Ltd. Recent Developments
11.9 Shire PLC
11.9.1 Shire PLC Company Details
11.9.2 Shire PLC Business Overview
11.9.3 Shire PLC Metabolic Disorder Therapeutics Introduction
11.9.4 Shire PLC Revenue in Metabolic Disorder Therapeutics Business (2017-2022)
11.9.5 Shire PLC Recent Developments
11.10 AbbVie, Inc.
11.10.1 AbbVie, Inc. Company Details
11.10.2 AbbVie, Inc. Business Overview
11.10.3 AbbVie, Inc. Metabolic Disorder Therapeutics Introduction
11.10.4 AbbVie, Inc. Revenue in Metabolic Disorder Therapeutics Business (2017-2022)
11.10.5 AbbVie, Inc. Recent Developments
11.11 Biocon Ltd.
11.11.1 Biocon Ltd. Company Details
11.11.2 Biocon Ltd. Business Overview
11.11.3 Biocon Ltd. Metabolic Disorder Therapeutics Introduction
11.11.4 Biocon Ltd. Revenue in Metabolic Disorder Therapeutics Business (2017-2022)
11.11.5 Biocon Ltd. Recent Developments
11.12 BioMarin Pharmaceutical, Inc.
11.12.1 BioMarin Pharmaceutical, Inc. Company Details
11.12.2 BioMarin Pharmaceutical, Inc. Business Overview
11.12.3 BioMarin Pharmaceutical, Inc. Metabolic Disorder Therapeutics Introduction
11.12.4 BioMarin Pharmaceutical, Inc. Revenue in Metabolic Disorder Therapeutics Business (2017-2022)
11.12.5 BioMarin Pharmaceutical, Inc. Recent Developments
11.13 Bristol-Myers Squibb Company
11.13.1 Bristol-Myers Squibb Company Company Details
11.13.2 Bristol-Myers Squibb Company Business Overview
11.13.3 Bristol-Myers Squibb Company Metabolic Disorder Therapeutics Introduction
11.13.4 Bristol-Myers Squibb Company Revenue in Metabolic Disorder Therapeutics Business (2017-2022)
11.13.5 Bristol-Myers Squibb Company Recent Developments
11.14 Cipla, Inc.
11.14.1 Cipla, Inc. Company Details
11.14.2 Cipla, Inc. Business Overview
11.14.3 Cipla, Inc. Metabolic Disorder Therapeutics Introduction
11.14.4 Cipla, Inc. Revenue in Metabolic Disorder Therapeutics Business (2017-2022)
11.14.5 Cipla, Inc. Recent Developments
11.15 CymaBay Therapeutics, Inc.
11.15.1 CymaBay Therapeutics, Inc. Company Details
11.15.2 CymaBay Therapeutics, Inc. Business Overview
11.15.3 CymaBay Therapeutics, Inc. Metabolic Disorder Therapeutics Introduction
11.15.4 CymaBay Therapeutics, Inc. Revenue in Metabolic Disorder Therapeutics Business (2017-2022)
11.15.5 CymaBay Therapeutics, Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Metabolic Disorder Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Lysosomal Storage Diseases
Table 3. Key Players of Diabetes
Table 4. Key Players of Obesity
Table 5. Key Players of Inherited Metabolic Disorders
Table 6. Key Players of Hypercholesterolemia
Table 7. Global Metabolic Disorder Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Metabolic Disorder Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Metabolic Disorder Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Metabolic Disorder Therapeutics Market Share by Region (2017-2022)
Table 11. Global Metabolic Disorder Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Metabolic Disorder Therapeutics Market Share by Region (2023-2028)
Table 13. Metabolic Disorder Therapeutics Market Trends
Table 14. Metabolic Disorder Therapeutics Market Drivers
Table 15. Metabolic Disorder Therapeutics Market Challenges
Table 16. Metabolic Disorder Therapeutics Market Restraints
Table 17. Global Metabolic Disorder Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Metabolic Disorder Therapeutics Revenue Share by Players (2017-2022)
Table 19. Global Top Metabolic Disorder Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabolic Disorder Therapeutics as of 2021)
Table 20. Ranking of Global Top Metabolic Disorder Therapeutics Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Metabolic Disorder Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Metabolic Disorder Therapeutics Product Solution and Service
Table 24. Date of Enter into Metabolic Disorder Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Metabolic Disorder Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Metabolic Disorder Therapeutics Revenue Market Share by Type (2017-2022)
Table 28. Global Metabolic Disorder Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Metabolic Disorder Therapeutics Revenue Market Share by Type (2023-2028)
Table 30. Global Metabolic Disorder Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Metabolic Disorder Therapeutics Revenue Share by Application (2017-2022)
Table 32. Global Metabolic Disorder Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Metabolic Disorder Therapeutics Revenue Share by Application (2023-2028)
Table 34. North America Metabolic Disorder Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Metabolic Disorder Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Metabolic Disorder Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Metabolic Disorder Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Metabolic Disorder Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Metabolic Disorder Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Metabolic Disorder Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Metabolic Disorder Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Metabolic Disorder Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Metabolic Disorder Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Metabolic Disorder Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Metabolic Disorder Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Metabolic Disorder Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Metabolic Disorder Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Metabolic Disorder Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Metabolic Disorder Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Metabolic Disorder Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Metabolic Disorder Therapeutics Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Metabolic Disorder Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Metabolic Disorder Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Metabolic Disorder Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Metabolic Disorder Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Metabolic Disorder Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Metabolic Disorder Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Metabolic Disorder Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Metabolic Disorder Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Metabolic Disorder Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Metabolic Disorder Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Metabolic Disorder Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Metabolic Disorder Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 64. Novo Nordisk A/S Company Details
Table 65. Novo Nordisk A/S Business Overview
Table 66. Novo Nordisk A/S Metabolic Disorder Therapeutics Product
Table 67. Novo Nordisk A/S Revenue in Metabolic Disorder Therapeutics Business (2017-2022) & (US$ Million)
Table 68. Novo Nordisk A/S Recent Developments
Table 69. Sanofi S.A. Company Details
Table 70. Sanofi S.A. Business Overview
Table 71. Sanofi S.A. Metabolic Disorder Therapeutics Product
Table 72. Sanofi S.A. Revenue in Metabolic Disorder Therapeutics Business (2017-2022) & (US$ Million)
Table 73. Sanofi S.A. Recent Developments
Table 74. Boehringer Ingelheim GmbH Company Details
Table 75. Boehringer Ingelheim GmbH Business Overview
Table 76. Boehringer Ingelheim GmbH Metabolic Disorder Therapeutics Product
Table 77. Boehringer Ingelheim GmbH Revenue in Metabolic Disorder Therapeutics Business (2017-2022) & (US$ Million)
Table 78. Boehringer Ingelheim GmbH Recent Developments
Table 79. Eli Lilly and Company Company Details
Table 80. Eli Lilly and Company Business Overview
Table 81. Eli Lilly and Company Metabolic Disorder Therapeutics Product
Table 82. Eli Lilly and Company Revenue in Metabolic Disorder Therapeutics Business (2017-2022) & (US$ Million)
Table 83. Eli Lilly and Company Recent Developments
Table 84. Merck KgaA Company Details
Table 85. Merck KgaA Business Overview
Table 86. Merck KgaA Metabolic Disorder Therapeutics Product
Table 87. Merck KgaA Revenue in Metabolic Disorder Therapeutics Business (2017-2022) & (US$ Million)
Table 88. Merck KgaA Recent Developments
Table 89. Amgen, Inc. Company Details
Table 90. Amgen, Inc. Business Overview
Table 91. Amgen, Inc. Metabolic Disorder Therapeutics Product
Table 92. Amgen, Inc. Revenue in Metabolic Disorder Therapeutics Business (2017-2022) & (US$ Million)
Table 93. Amgen, Inc. Recent Developments
Table 94. AstraZeneca PLC Company Details
Table 95. AstraZeneca PLC Business Overview
Table 96. AstraZeneca PLC Metabolic Disorder Therapeutics Product
Table 97. AstraZeneca PLC Revenue in Metabolic Disorder Therapeutics Business (2017-2022) & (US$ Million)
Table 98. AstraZeneca PLC Recent Developments
Table 99. Actelion Pharmaceuticals Ltd. Company Details
Table 100. Actelion Pharmaceuticals Ltd. Business Overview
Table 101. Actelion Pharmaceuticals Ltd. Metabolic Disorder Therapeutics Product
Table 102. Actelion Pharmaceuticals Ltd. Revenue in Metabolic Disorder Therapeutics Business (2017-2022) & (US$ Million)
Table 103. Actelion Pharmaceuticals Ltd. Recent Developments
Table 104. Shire PLC Company Details
Table 105. Shire PLC Business Overview
Table 106. Shire PLC Metabolic Disorder Therapeutics Product
Table 107. Shire PLC Revenue in Metabolic Disorder Therapeutics Business (2017-2022) & (US$ Million)
Table 108. Shire PLC Recent Developments
Table 109. AbbVie, Inc. Company Details
Table 110. AbbVie, Inc. Business Overview
Table 111. AbbVie, Inc. Metabolic Disorder Therapeutics Product
Table 112. AbbVie, Inc. Revenue in Metabolic Disorder Therapeutics Business (2017-2022) & (US$ Million)
Table 113. AbbVie, Inc. Recent Developments
Table 114. Biocon Ltd. Company Details
Table 115. Biocon Ltd. Business Overview
Table 116. Biocon Ltd. Metabolic Disorder Therapeutics Product
Table 117. Biocon Ltd. Revenue in Metabolic Disorder Therapeutics Business (2017-2022) & (US$ Million)
Table 118. Biocon Ltd. Recent Developments
Table 119. BioMarin Pharmaceutical, Inc. Company Details
Table 120. BioMarin Pharmaceutical, Inc. Business Overview
Table 121. BioMarin Pharmaceutical, Inc. Metabolic Disorder Therapeutics Product
Table 122. BioMarin Pharmaceutical, Inc. Revenue in Metabolic Disorder Therapeutics Business (2017-2022) & (US$ Million)
Table 123. BioMarin Pharmaceutical, Inc. Recent Developments
Table 124. Bristol-Myers Squibb Company Company Details
Table 125. Bristol-Myers Squibb Company Business Overview
Table 126. Bristol-Myers Squibb Company Metabolic Disorder Therapeutics Product
Table 127. Bristol-Myers Squibb Company Revenue in Metabolic Disorder Therapeutics Business (2017-2022) & (US$ Million)
Table 128. Bristol-Myers Squibb Company Recent Developments
Table 129. Cipla, Inc. Company Details
Table 130. Cipla, Inc. Business Overview
Table 131. Cipla, Inc. Metabolic Disorder Therapeutics Product
Table 132. Cipla, Inc. Revenue in Metabolic Disorder Therapeutics Business (2017-2022) & (US$ Million)
Table 133. Cipla, Inc. Recent Developments
Table 134. CymaBay Therapeutics, Inc. Company Details
Table 135. CymaBay Therapeutics, Inc. Business Overview
Table 136. CymaBay Therapeutics, Inc. Metabolic Disorder Therapeutics Product
Table 137. CymaBay Therapeutics, Inc. Revenue in Metabolic Disorder Therapeutics Business (2017-2022) & (US$ Million)
Table 138. CymaBay Therapeutics, Inc. Recent Developments
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Metabolic Disorder Therapeutics Market Share by Type: 2021 VS 2028
Figure 2. Lysosomal Storage Diseases Features
Figure 3. Diabetes Features
Figure 4. Obesity Features
Figure 5. Inherited Metabolic Disorders Features
Figure 6. Hypercholesterolemia Features
Figure 7. Global Metabolic Disorder Therapeutics Market Share by Application: 2021 VS 2028
Figure 8. Oral Case Studies
Figure 9. Parenteral Case Studies
Figure 10. Others Case Studies
Figure 11. Metabolic Disorder Therapeutics Report Years Considered
Figure 12. Global Metabolic Disorder Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Metabolic Disorder Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Metabolic Disorder Therapeutics Market Share by Region: 2021 VS 2028
Figure 15. Global Metabolic Disorder Therapeutics Market Share by Players in 2021
Figure 16. Global Top Metabolic Disorder Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabolic Disorder Therapeutics as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Metabolic Disorder Therapeutics Revenue in 2021
Figure 18. North America Metabolic Disorder Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Metabolic Disorder Therapeutics Market Size Market Share by Type (2017-2028)
Figure 20. North America Metabolic Disorder Therapeutics Market Size Market Share by Application (2017-2028)
Figure 21. North America Metabolic Disorder Therapeutics Market Size Share by Country (2017-2028)
Figure 22. United States Metabolic Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Metabolic Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Metabolic Disorder Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Metabolic Disorder Therapeutics Market Size Market Share by Type (2017-2028)
Figure 26. Europe Metabolic Disorder Therapeutics Market Size Market Share by Application (2017-2028)
Figure 27. Europe Metabolic Disorder Therapeutics Market Size Share by Country (2017-2028)
Figure 28. Germany Metabolic Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Metabolic Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Metabolic Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Metabolic Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Metabolic Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Metabolic Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Metabolic Disorder Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Metabolic Disorder Therapeutics Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Metabolic Disorder Therapeutics Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Metabolic Disorder Therapeutics Market Size Share by Region (2017-2028)
Figure 38. China Metabolic Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Metabolic Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Metabolic Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Metabolic Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Metabolic Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Metabolic Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Latin America Metabolic Disorder Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Metabolic Disorder Therapeutics Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Metabolic Disorder Therapeutics Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Metabolic Disorder Therapeutics Market Size Share by Country (2017-2028)
Figure 48. Mexico Metabolic Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Metabolic Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Metabolic Disorder Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Metabolic Disorder Therapeutics Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Metabolic Disorder Therapeutics Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Metabolic Disorder Therapeutics Market Size Share by Country (2017-2028)
Figure 54. Turkey Metabolic Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Metabolic Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Metabolic Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Novo Nordisk A/S Revenue Growth Rate in Metabolic Disorder Therapeutics Business (2017-2022)
Figure 58. Sanofi S.A. Revenue Growth Rate in Metabolic Disorder Therapeutics Business (2017-2022)
Figure 59. Boehringer Ingelheim GmbH Revenue Growth Rate in Metabolic Disorder Therapeutics Business (2017-2022)
Figure 60. Eli Lilly and Company Revenue Growth Rate in Metabolic Disorder Therapeutics Business (2017-2022)
Figure 61. Merck KgaA Revenue Growth Rate in Metabolic Disorder Therapeutics Business (2017-2022)
Figure 62. Amgen, Inc. Revenue Growth Rate in Metabolic Disorder Therapeutics Business (2017-2022)
Figure 63. AstraZeneca PLC Revenue Growth Rate in Metabolic Disorder Therapeutics Business (2017-2022)
Figure 64. Actelion Pharmaceuticals Ltd. Revenue Growth Rate in Metabolic Disorder Therapeutics Business (2017-2022)
Figure 65. Shire PLC Revenue Growth Rate in Metabolic Disorder Therapeutics Business (2017-2022)
Figure 66. AbbVie, Inc. Revenue Growth Rate in Metabolic Disorder Therapeutics Business (2017-2022)
Figure 67. Biocon Ltd. Revenue Growth Rate in Metabolic Disorder Therapeutics Business (2017-2022)
Figure 68. BioMarin Pharmaceutical, Inc. Revenue Growth Rate in Metabolic Disorder Therapeutics Business (2017-2022)
Figure 69. Bristol-Myers Squibb Company Revenue Growth Rate in Metabolic Disorder Therapeutics Business (2017-2022)
Figure 70. Cipla, Inc. Revenue Growth Rate in Metabolic Disorder Therapeutics Business (2017-2022)
Figure 71. CymaBay Therapeutics, Inc. Revenue Growth Rate in Metabolic Disorder Therapeutics Business (2017-2022)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Industry Market Size
